Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

16.09.20	ARPO To Report Glaucoma Trial Data In Q4, ARDX To Face FDA In April, PFE's Pipeline Update (RTTNews)
15.09.20	Pfizer Investor Day Features Significant Number of Pipeline Advances for COVID-19 Programs and Across Numerous Therapeutic Areas (Businesswire)
15.09.20	BioNTech To Receive Up To €375 Mln In Funding From German To Support COVID-19 Vaccine Program (RTTNews)
14.09.20	Pfizer Hosts Virtual Investor Day (Businesswire)
12.09.20	Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial (Businesswire)
11.09.20	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
10.09.20	Pfizer to Present Latest Scientific Advancements from Its Industry-Leading Portfolio at the ESMO Virtual Congress 2020 (Businesswire)
09.09.20	Pfizer, BioNTech Say MRNA-based Vaccine Candidate Protected Rhesus Macaques In Preclinical Studies (RTTNews)
09.09.20	Pfizer, BioNTech Enter Contract Negotiations With EU To Supply SARS-CoV-2 Vaccine (RTTNews)
09.09.20	AZN Pauses COVID-19 Vaccine Trial, ALBO Hits New High, CRBP Plunges, PFE To Invest In TRIL (RTTNews)
08.09.20	Biopharma Leaders Unite to Stand with Science (Businesswire)
04.09.20	Pfizer Covid-19 Vaccine Update Likely In October (RTTNews)
03.09.20	Pfizer Invites Public to Register for Webcast of Virtual Investor Day on September 14 and 15, 2020 (Businesswire)
25.08.20	Exxon Mobil, Pfizer Exit Dow Jones Industrial Average (RTTNews)
21.08.20	Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19 (Businesswire)
21.08.20	Pfizer, BioNTech Announce Positive Early Data On MRNA Vaccine Candidate BNT162b2 Against COVID-19 (RTTNews)
12.08.20	U.S. Reaches Deal With Moderna For 100 Million Doses Of COVID-19 Vaccine (RTTNews)
11.08.20	CPRX Plunges As MuSK-MG Trial Flops, MESO Awaits FDA Panel Review, EQ Soars After-hrs (RTTNews)
07.08.20	Pfizer Signs Deal To Boost Supply Of Gilead's Remdesivir For COVID-19 Patients (RTTNews)
07.08.20	Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-19 (Businesswire)
06.08.20	Pfizer Announces Times for Rescheduled Virtual Investor Day on September 14 and September 15, 2020 (Businesswire)
06.08.20	ABIO To Start Phase 2 COVID-19 Trial In Q4, ACIU On Track, BCLI Expects ALS Trial Data In Nov. (RTTNews)
05.08.20	Pfizer: Phase 3 CROWN Study Of LORBRENA Meets Primary Endpoint (RTTNews)
05.08.20	LORBRENA® (lorlatinib) Significantly Improves Progression-Free Survival in First-Line ALK-Positive Lung Cancer (Businesswire)
31.07.20	Pfizer, BioNTech To Supply 120 Mln Doses Of BNT162 MRNA-based SARS-CoV2 Vaccine Candidate To Japan (RTTNews)
31.07.20	Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate (Businesswire)
28.07.20	Pfizer Q2 Profit Tops Estimates; Revenues Down 11%; Raises Guidance (RTTNews)
28.07.20	Pfizer Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
28.07.20	Pfizer Reports Second-Quarter 2020 Results (Businesswire)
28.07.20	MRNA, PFE/BNTX COVID-19 Vaccines Move Into Phase 3, CytoDyn On Watch, GNCA To Report Data On Jul.30 (RTTNews)
28.07.20	Pfizer And BioNTech Start Late-stage Study Of COVID-19 Vaccine Candidate (RTTNews)
27.07.20	Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2/3 Global Study (Businesswire)
24.07.20	Pre-market Movers In Healthcare Sector: THTX, ABUS, QLGN CNTG, MRNA… (RTTNews)
22.07.20	Pfizer, BioNTech Agree To Supply Initial 100 Mln Doses Of COVID-19 Vaccine To Americans (RTTNews)
22.07.20	Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2 (Businesswire)
20.07.20	Pfizer, BioNTech Report Positive Update From German Phase 1/2 Covid-19 Vaccine Study (RTTNews)
20.07.20	Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data (Businesswire)
20.07.20	Pfizer, BioNTech Reach Deal With U.K. To Supply 30 Mln Doses Of Potential Covid-19 Vaccine (RTTNews)
20.07.20	Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2 (Businesswire)
19.07.20	Clinical Trial Readouts Of COVID-19 Vaccines, Drugs Due In July (RTTNews)
14.07.20	Pre-market Movers In Healthcare Sector: INMB, ECOR, CYAD, VXRT... (RTTNews)
14.07.20	EQ Soars, INMB Up On Promising Alzheimer's Trial Data, ALT To Move AdCOVID Into Clinical Trial In Q4 (RTTNews)
13.07.20	Pfizer, BioNTech Granted FDA Fast Track Designation For Two COVID-19 Vaccine Candidates (RTTNews)
13.07.20	Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2 (Businesswire)
09.07.20	Pfizer Pledges $100 Million to New Industry Fund to Help Fight Growing Threat of Antimicrobial Resistance (Businesswire)
02.07.20	LMNL Joins COVID-19 Battle, PFE/BNTX Vaccine Data Promising, EVLO On Watch (RTTNews)
01.07.20	Pfizer And BioNTech' Potential Covid-19 Vaccine Shows Positive Data In Human Trial (RTTNews)
01.07.20	Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2 (Businesswire)
01.07.20	EMD Serono, Pfizer: FDA Approves SBLA For BAVENCIO (RTTNews)
25.06.20	Pfizer Declares Third-Quarter 2020 Dividend (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V

mehr

18.12.24		Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten
18.12.24		Pluszeichen in Europa: STOXX 50 letztendlich fester
18.12.24		Minuszeichen in Zürich: SMI legt letztendlich den Rückwärtsgang ein
18.12.24		Börse Zürich in Rot: SPI schliesst in der Verlustzone
18.12.24		Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester
18.12.24		Freundlicher Handel in London: FTSE 100 notiert zum Ende des Mittwochshandels im Plus
18.12.24		Zuversicht in Frankfurt: Zum Ende des Mittwochshandels Pluszeichen im TecDAX
18.12.24		Aufschläge in Frankfurt: SDAX steigt zum Handelsende

18.12.24

Dow Jones-Handel aktuell: Dow Jones beendet den Mittwochshandel mit Verlusten

18.12.24

Pluszeichen in Europa: STOXX 50 letztendlich fester

18.12.24

Minuszeichen in Zürich: SMI legt letztendlich den Rückwärtsgang ein

18.12.24

Börse Zürich in Rot: SPI schliesst in der Verlustzone

18.12.24

Handel in Europa: Euro STOXX 50 präsentiert sich letztendlich fester

18.12.24

Freundlicher Handel in London: FTSE 100 notiert zum Ende des Mittwochshandels im Plus